For most of us the summer has come upon, and we hope you enjoyed the season. In May the Board of Directors decided that Sydney, Australia will be the host for the 15th World Conference on Lung Cancer 2013.
Applications for the 16th World Conference in North America is announced in this Newsletter. Guidelines for application can be found at www.iaslc.org
Please note that in 2009, new members of the Board of Directors will be elected. Candidate names should be submitted to the chair of the Nominating Committee Dr. Raymond Abratt, firstname.lastname@example.org . Among the new members of the Board of Directors is the President Elect from Europe and a new Treasurer.
The Board of Directors is currently working on a long-term organizational strategy for the IASLC, and planning to seek external advice from professional companies on how to move the organization forward in the future. Any ideas from the IASLC members can be forwarded to the IASLC Executive Office.
Fred R. Hirsch, MD, PhD
Editor, IASLC Newsletter
2008 Chicago Multidisciplinary Symposium in Thoracic Oncology:
The 2009 Chicago Multidisciplinary Symposium in Thoracic Oncology will take place November 13-15, 2008.
Announcement of WCLC 2015 – North America
IASLCInvitation to host 16th World Conference on Lung Cancer 2015
The IASLC World Conference is soliciting bids for the 16th World Conference on Lung Cancer to take place in North America.
The IASLC World Conference on Lung Cancer is held every second year and will take place in North American 2015. The attendance can be expected to range from 8,000 – 10,000 (including accompanying persons)
The proposal should include the following:
- Location- The 16th World Conference will take place in a North America country.
- Time period - The duration of the Conference is 4-5 days.
- Facilities (for conferences, workshops, hotels, etc.) - The meeting must take place in a location with adequate facilities to comfortably accommodate the expected attendance (up to 10,000) Flight connections must be accessible from anywhere in the world.
- Organizers - The group should include persons with a demonstrated track record within the IASLC who can put together a small local Organizing Program Committee to coordinate the planning of the meeting, and they should preferably have previous experience with similar arrangements.
- Local/national support - If possible, support should be requested from national societies or local organizers.
- Budget proposal - A detailed budget must outline all expected revenues and expenses.
- Suggestions for social events
A copy of the detailed ‘Guidelines for the International Association for the Study of Lung Cancer World Conferences’ can be obtained from the IASLC website www.iaslc.org.
Applications will be accepted after September 2008, and not later than December 1, 2008. The applications will be reviewed by the IASLC Board of Directors at the Board meeting in February 2008. Finalists will be notified in March 2008 and selected IASLC Officers, staff, Board members will conduct site visits to the finalist sites in the spring of 2009. A final decision will be made no later than the Board meeting in June 2009.
Further information can be obtained from members of the Board and from the IASLC Office.
Please apply by e-mail email@example.com latest December 1st, 2008. by mail:
International Association for the Study of Lung Cancer
Executive Director Paul A. Bunn, Jr., MD
University of Colorado Cancer Center
P.O.Box 6508, MS F 434, Aurora, Colorado 80045-0511, USA
1st IASLC ESMO European Lung Cancer Conference, Geneva,
Switzerland, April 2008 – Virtual meeting is freely accessible.
We are delighted to report that the 1st European Lung Cancer Conference jointly organized by ESMO and IASLC was a success, with 1383 participants from 73 countries taking part in the event.
The Conference virtual meeting is now available on our website www.iaslc.org – Please touch the logo for the meeting and the abstracts and presentation from the conference will be available. The virtual meeting of the meeting is freely accessible.
Paul A Bunn Jr. MD. Executive Director of IASLC and Director of the Colorado Cancer Center, was recently awarded the first Addario Foundation Lectureship presented at Ninth International Lung Cancer Congress in Hawaii, June 2008. The Addario Foundation Award was presented by the co-founder of the Foundation, Dr. David Jablons and the Conference President, Dr. David Gandara.
Dr. Jin Soo Lee, MD, PhD, IASLC Congress President 2007 is, as of June 17, 2008, the 4th President of the National Cancer Center of Korea, appointed by the Minister of Health, Welfare and Family Affairs to succeed Dr. Keun-Young YOO.
Dr. Corey Langer, MD, a well known medical oncologist , who led the Thoracic Oncology Program at Fox Chase Cancer Center, has recently been appointed as Director of the Thoracic Oncology Program at the University of Pennsylvania Cancer Center.
The National Lung Cancer Partnership announces the opening of the application period for two award programs:
National Lung Cancer Partnership/ LUNGevity Foundation Research Grants for the promotion of understanding lung cancer risk, biology, and response to treatment. This grant program, administered by the National Lung Cancer Partnership and co-funded with the LUNGevity Foundation, is designed to provide seed money for promising novel research in lung cancer for faculty members at any point in their careers, performing research at any institution world-wide. Two grants are available:
- One is specifically for research in the area of sex differences in lung cancer.
- One is for research pertaining to any facet of lung cancer.
Research Grants will be awarded for one or two years, for up to $50,000 per year ($100,000 maximum over 2 years).
National Lung Cancer Partnership Career Development Award for junior clinical and basic investigators involved in lung cancer etiology, prevention, and treatment at any U.S. or Canadian research institution. The National Lung Cancer Partnership’s goal is to create a critical mass of lung cancer researchers to ensure that basic and behavioral research discoveries are effectively translated into patient therapies to reduce lung cancer incidence, morbidity and mortality. Applicants will be judged on the merits of their research proposal, career development plan, and research environment, among other factors. Applicants must be post-doctoral fellows, or within the first five years of a faculty appointment. Career Development Awards will be awarded for one or two years, for up to $50,000 per year ($100,000 maximum over 2 years).
For application eligibility and instructions for these Grant & Award competitions, please visit the National Lung Cancer Partnership website at www.NationalLungCancerPartnership.org. Application deadline is September 2, 2008.
New members from May to July 2008:
Ian De Roock
J. Marie Suga
Sheila Von Driska
August 21-24, 2008
2008 Australian Lung Cancer Conference
Place: Queensland, Australia
For more information: firstname.lastname@example.org
ALCC Travel Scholarship information now available
October 1-5, 2008
International Thoracic Oncology Congress
Place: Dresden, Germany
For more information: email@example.com
October 9-10, 2008
3rd Latin American Cancer Conference
Place: Vina del Mar, Chile
Contact: Nise Yamaguchi, MD
For more information: firstname.lastname@example.org or Rodrigo.email@example.com
November 13-15, 2008
Malignancies of the Chest and Head and Neck
Place: Chicago, Illinois
For more information: firstname.lastname@example.org
December 5-7, 2008
3rd Asia Pacific Lung Cancer Congress
Place: Convention Center - Hotel Marriott Hyderabad - Hyderabad, India
Contact: Dr. AA Ranade email@example.com
For more information: firstname.lastname@example.org
April 1-5, 2009
4th IASLC/ASCO/ESMO International Conference on Targeted Therapies on Lung Cancer.
Place: Saint Paul de Vence, France
For more information: pia.hirsch@uchsc.
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
Journal of Thoracic Oncology
The IASLC’s premier journal, emphasizing a multidisciplinary approach including original research (clinical trials and translational or basic research), reviews and opinion pieces. Visit JTO